Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting in Melbourne

NECA CEO attends AGITG

NECA CEO, Meredith Cummins has attended the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting in Melbourne 14 – 17 November 2022.

This has been a fabulous meeting with international speakers, Australian HCPs and NZ HCPs.

The meeting has provided updates on clinical trials with topics such as genomics, genetic testing, Artificial Intelligence (AI), personalised treatment, including an update on CONTROLNETs by Prof Nick Pavlakis and future plans for the subsequent trial in planning.

It was also so beneficial, with being able to network with many of our clinicians (many from our PLANET Registry committee), industry and other healthcare professionals. The networking provided opportunities to work together for projects, education and care co-ordination.

Australia is doing amazing work in clinical trials, and it has been a pleasure to be part of this meeting.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Racing for a Cure 2026 – thank you Rob!

NECA Joins Cancer Australia’s Low Survival Cancers Mission Roundtable

NECA CEO Meredith Cummins named Health and Social Services Government Relations Practitioner of the Year

The Faces of HTA Reform booklet is here

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.